Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Clinical Genitourinary Cancer|February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate CancerDaniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.Nature Genetics|February 22, 2024
Chromosome evolution screens recapitulate tissue-specific tumor aneuploidy patternsEmma V Watson, Jake June-Koo Lee, Doga C Gulhan, et al.NPJ Precision Oncology|December 29, 2022
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancerFernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, et al.Nature Genetics|March 20, 2019
Linked-read analysis identifies mutations in single-cell DNA-sequencing dataCraig L Bohrson, Alison R Barton, Michael A Lodato, et al.Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Liquid Biopsy of HPV Cell-Free DNA Enables Blood-Based Early Detection and Molecular Stratification of HPV-Associated Cancer and Precancer StagesQin Wang, Samuli Eldfors, Sangmi Sandra Lee, et al.Nature|May 17, 2023
ERα-associated translocations underlie oncogene amplifications in breast cancerJake June-Koo Lee, Youngsook Lucy Jung, Taek-Chin Cheong, et al.Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signaturesDoga C Gulhan, Vinay Viswanadham, Francesc Muyas, et al.Nature Neuroscience|January 12, 2021
The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencingRachel E Rodin, Yanmei Dou, Minseok Kwon, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
A chromatin fiber model explains cell-free DNA fragmentation signatures of active regulatory elementsAlexis Yang, Garyoung Gary Lee, Surya Chhetri, et al.Cancer Research|January 30, 2021
Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in <i>TP53-</i> and <i>BRCA1</i>-Deficient CellsAnniina Färkkilä, Alfredo Rodríguez, Jaana Oikkonen, et al.Pageof 4